Q3 2024 Rxsight Inc Earnings Call Transcript
Key Points
- RxSight Inc (RXST) reported a 59% increase in revenue for Q3 2024 compared to the same period last year, reaching $35.3 million.
- The company experienced robust growth in its LDD installed base, surpassing typical seasonal expectations.
- Gross margin improved to 71.4% in Q3 2024, up from 61.9% in the same quarter last year, reflecting a favorable product mix and cost efficiencies.
- RxSight Inc (RXST) successfully rolled out LAL Plus in the US and received approval in Canada, enhancing its product offerings.
- The company is expanding its market presence by targeting optometrists, who play a key role in patient diagnosis and decision-making.
- LAL sales were impacted by seasonal trends and external factors such as hurricanes, which affected surgery days.
- SG&A expenses increased by 34% year-over-year, driven by higher personnel costs and stock-based compensation.
- R&D expenses rose by 24.5% compared to the previous year, primarily due to increased facilities costs and new hires.
- The company reported a GAAP net loss of $6.3 million for Q3 2024, although this was an improvement from the previous year's loss.
- Despite strong growth, the company faces challenges in maintaining high utilization rates across all practices, with some variability in adoption.
Thank you for standing by. My name is Andrea and I will be your conference operator today. At this time, I would like to welcome everyone to the Rx I third quarter, 2024 earnings conference call. All lines have been placed in mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again, I would now like to turn the call over to Oliver Moravcevic, Vice President of Investor Relations. Thank you. Please go ahead.
Thank you operator presenting today are Rxsight President and Chief Executive Officer, Dr Ron Kurtz and Chief Financial Officer Shelley Tuan. Earlier today, Rite released financial results for the three months ended. September 30, 2024. A copy of the press release is available on the company's website before we begin. I would like to inform you that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
